Veterinary Medicines

Advantage 100 Spot-on Solution for Dogs

Authorised
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
Advantage 100 mg Lösung zum Auftropfen für Hunde (≥ 4 - < 10 kg)
Advantage 100 Spot-on Solution for Dogs
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Pack sizes 1 ml solution per pipette, Pack containing 1 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 1 ml solution per pipette, Pack containing 2 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 1 ml solution per pipette, Pack containing 3 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 1 ml solution per pipette, Pack containing 4 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 1 ml solution per pipette, Pack containing 6 unit dose pipettes, Container: White polypropylene pipettes with caps

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 52127/3065
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0020/002
Concerned member states:
  • Denmark
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."